Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Defence Therapeutics Inc
C.DTC
Alternate Symbol(s):
DTCFF
Healthcare
Biotechnology
Defence Therapeutics Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and engineering the radio-immuno-conjugate and antibody drug conjugates (ADC) products using its proprietary platform in addition to immune-oncology vaccines. Its principal business activity is the development of a biological drug enhancer platform that improves the efficacy and safety of a...
multitude of biological-/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The core of its therapeutics platform is the ACCUM technology, which enables precision delivery of radio-immuno-conjugates or ADCs in their intact form to target cells, and vaccine antigens. The Company is focused on research, development and advancement of the main products using its Accum technology, which include ADC targeting various cancers, Anti-cancer AccuTOX program, Mesenchymal stromal cell-based vaccine (ARM-X) targeting cancer and mRNA vaccination.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DTC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Feb 21, 2025 2:18pm
DTC artice from Germany
https://news.financial/interviews/revolutionizing-cancer-treatment-how-defence-therapeutics-platform-enhances-drug-efficacy-and-targets-cancer-cells-with-precisio
(27)
•••
Skyrocket666
X
Post by
Skyrocket666
on Feb 19, 2025 11:53pm
BNXT the next DTC
I am hearing that BNXT on the CSE will be the next one to move up like DTC https://news.financial/comments/pharma-in-focus-bayer-bionxt-solutions-novo-nordisk-market-development-innovation
...more
(394)
•••
Tarbaby
X
Post by
Tarbaby
on Sep 20, 2024 7:55pm
DTC IS DOING WELL
I really like what I see here. Buying. This stock will move. Good new head man..very competent. Imo.
(869)
•••
Pandora
X
Comment by
Pandora
on Jul 04, 2024 3:53pm
RE:Defence Successfully Completes the First Milestone
It's a personal thing but I would like to see someone develop a med or vaccine for Dengue Fever. My son is over in Bali and has just contracted it for the second time. It comes from mosquitos and
...more
(4)
•••
VenturistAlly
X
Comment by
VenturistAlly
on May 02, 2024 2:19pm
RE:RE:RE:Defence Therapeutics’ Shows Pancreatic Cancer Promise -
you're looking smart!
(8)
•••
eddy0505
X
Comment by
eddy0505
on May 01, 2024 3:28pm
RE:RE:Defence Therapeutics’ Shows Pancreatic Cancer Promise -
Yes. Agree. Took a position today
(4)
•••
VenturistAlly
X
Comment by
VenturistAlly
on May 01, 2024 3:19pm
RE:Defence Therapeutics’ Shows Pancreatic Cancer Promise -
flying under radar. science is starting to smell like billion dollar buyouts seen in other immotherapy comparables big blocks trading today. strategic positioning?
(8)
•••
eddy0505
X
Post by
eddy0505
on May 01, 2024 3:14pm
Defence Therapeutics’ Shows Pancreatic Cancer Promise -
Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccine Newsfile 11 hours ago
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jul 18, 2023 2:27pm
Defence Successfully Completes the First Milestone
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company") is pleased to
...more
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on May 26, 2023 5:34pm
Exercise of Warrants for Gross Proceeds of Over $2.3 M C.DTC
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian
...more
(15)
•••
havana888
X
Post by
havana888
on Jan 17, 2023 2:24pm
...Defence ...
I increase my prospects to 10 CAD
(16)
•••
Stocks2Go
X
Comment by
Stocks2Go
on Jan 06, 2023 1:13pm
RE:...Defence ...
yes it's climbing steadily.
(15)
•••
havana888
X
Post by
havana888
on Jan 06, 2023 10:21am
...Defence ...
The next PR will be the hammer against cancer....I'm already looking forward to it today...have added 800 pieces and will continue to do so....7 CAD will soon be a reality...good luck friends
(294)
•••
TrevorAbes
X
Post by
TrevorAbes
on Aug 02, 2022 5:42pm
Defence Therapeutics’ AccuTOX shown to kill cancer cells
https://themarketherald.ca/defence-therapeutics-csedtc-accutox-shown-to-kill-cancer-cells-2022-08-02/
(2)
•••
Goldnboy1
X
Post by
Goldnboy1
on Oct 26, 2021 5:19pm
Mini DTC
You guys should grab some $APC It's the only micro cap sized stock available in Canada with a legitimate Covid Therapy development program. Apc just hired the former head scientist of
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers